M. Boeckh, Complications, Diagnosis, Management, and Prevention of CMV Infections: Current and Future, Hematology, vol.2011, issue.1, pp.305-314, 2011.
DOI : 10.1182/asheducation-2011.1.305

C. Kotton and . Cmv, Prevention, Diagnosis and Therapy American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, pp.24-40, 2013.

R. Razonable, A. Humar, and P. Astidco, Cytomegalovirus in solid organ transplantation American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, pp.93-106, 2013.

P. Ramanan and R. Razonable, Cytomegalovirus Infections in Solid Organ Transplantation: A Review, Infection & Chemotherapy, vol.45, issue.3, pp.260-71, 2013.
DOI : 10.3947/ic.2013.45.3.260

L. Borysiewicz, J. Hickling, S. Graham, J. Sinclair, M. Cranage et al., Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage-specific CTL recognizing the 72-kD immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses, Journal of Experimental Medicine, vol.168, issue.3, pp.919-950, 1988.
DOI : 10.1084/jem.168.3.919

M. Wills, A. Carmichael, K. Mynard, J. X. Weekes, M. Plachter et al., The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity , and T-cell receptor usage of pp65-specific CTL, Journal of virology. PMID, vol.70, issue.11, pp.7569-79, 1996.

R. Holtappels, V. Bohm, J. Podlech, and M. Reddehase, CD8 T-cell-based immunotherapy of cytomegalovirus infection: "proof of concept" provided by the murine model. Medical microbiology and immunology, pp.125-159, 2008.

S. Borchers, J. Ogonek, P. Varanasi, S. Tischer, M. Bremm et al., Multimer monitoring of CMV-specific T cells in research and in clinical applications. Diagnostic microbiology and infectious disease, pp.201-213, 2014.

G. Pietra, C. Romagnani, C. Manzini, L. Moretta, and M. Mingari, T Lymphocytes in the Adaptive Immune Response to Pathogens and Tumors, Journal of Biomedicine and Biotechnology, vol.29, issue.1, pp.907092907092-2896910, 2010.
DOI : 10.1084/jem.20091429

C. Grimsley, A. Kawasaki, C. Gassner, N. Sageshima, Y. Nose et al., Definitive high resolution typing of HLA-E allelic polymorphisms: Identifying potential errors in existing allele data, Tissue Antigens, vol.8, issue.3, pp.206-218, 2002.
DOI : 10.1101/gr.8.3.175

V. Prod-'homme, P. Tomasec, C. Cunningham, M. Lemberg, R. Stanton et al., Human Cytomegalovirus UL40 Signal Peptide Regulates Cell Surface Expression of the NK Cell Ligands HLA-E and gpUL18, The Journal of Immunology, vol.188, issue.6, pp.2794-804, 2012.
DOI : 10.4049/jimmunol.1102068

P. Tomasec, V. Braud, C. Rickards, M. Powell, B. Mcsharry et al., Surface Expression of HLA-E, an Inhibitor of Natural Killer Cells, Enhanced by Human Cytomegalovirus gpUL40, Science, vol.287, issue.5455, pp.1031-10669413, 2000.
DOI : 10.1126/science.287.5455.1031

V. Braud, D. Allan, O. Callaghan, C. Soderstrom, K. et al., HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C, Nature, vol.24, issue.6669, pp.795-804, 1998.
DOI : 10.1084/jem.178.4.1321

N. Lee, D. Goodlett, A. Ishitani, H. Marquardt, and D. Geraghty, HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences, Journal of immunology, vol.160, issue.10, pp.4951-60, 1998.

M. Ulbrecht, S. Martinozzi, M. Grzeschik, H. Hengel, J. Ellwart et al., Cutting Edge: The Human Cytomegalovirus UL40 Gene Product Contains a Ligand for HLA-E and Prevents NK Cell-Mediated Lysis, The Journal of Immunology, vol.164, issue.10, pp.5019-5041, 2000.
DOI : 10.4049/jimmunol.164.10.5019

URL : http://www.jimmunol.org/content/jimmunol/164/10/5019.full.pdf

E. Wang, B. Mcsharry, C. Retiere, P. Tomasec, S. Williams et al., UL40-mediated NK evasion during productive infection with human cytomegalovirus, Proceedings of the National Academy of Sciences, vol.96, issue.17, pp.7570-7575, 2002.
DOI : 10.1073/pnas.96.17.9839

URL : https://hal.archives-ouvertes.fr/hal-00089999

A. Rolle, J. Pollmann, E. Ewen, V. Le, A. Halenius et al., IL-12-producing monocytes and HLA-E control HCMV-driven NKG2C+ NK cell expansion. The Journal of clinical investigation, pp.5305-5321, 2014.

C. Romagnani, G. Pietra, M. Falco, E. Millo, P. Mazzarino et al., Identification of HLA-E-specific alloreactive T lymphocytes: A cell subset that undergoes preferential expansion in mixed lymphocyte culture and displays a broad cytolytic activity against allogeneic cells, Proceedings of the National Academy of Sciences, vol.295, issue.5562, pp.11328-11361, 2002.
DOI : 10.1126/science.1068440

G. Pietra, C. Romagnani, P. Mazzarino, M. Falco, E. Millo et al., HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+ cytolytic T lymphocytes, Proceedings of the National Academy of Sciences, vol.45, issue.90003, pp.10896-901, 2003.
DOI : 10.1093/jac/45.suppl_4.29

URL : http://www.pnas.org/content/100/19/10896.full.pdf

M. Allard, P. Tonnerre, S. Nedellec, R. Oger, A. Morice et al., HLA-E-Restricted Cross-Recognition of Allogeneic Endothelial Cells by CMV-Associated CD8 T Cells: A Potential Risk Factor following Transplantation, PLoS ONE, vol.11, issue.11, pp.50951-3511380, 2012.
DOI : 10.1371/journal.pone.0050951.s004

URL : https://hal.archives-ouvertes.fr/inserm-01726990

L. Sullivan, G. Westall, J. Widjaja, N. Mifsud, T. Nguyen et al., The Presence of HLA-E-Restricted, CMV-Specific CD8+ T Cells in the Blood of Lung Transplant Recipients Correlates with Chronic Allograft Rejection, PLOS ONE, vol.75, issue.8, p.4547726, 2015.
DOI : 10.1371/journal.pone.0135972.t003

H. Hoare, L. Sullivan, G. Pietra, C. Clements, E. Lee et al., Structural basis for a major histocompatibility complex class Ib???restricted T cell response, Nature Immunology, vol.59, issue.3, pp.256-64, 2006.
DOI : 10.1107/S0907444903008126

R. Strong, M. Holmes, P. Li, L. Braun, N. Lee et al., HLA-E Allelic Variants, Journal of Biological Chemistry, vol.160, issue.7, pp.5082-90, 2003.
DOI : 10.1107/S0021889892009944

URL : http://www.jbc.org/content/278/7/5082.full.pdf

S. Heatley, G. Pietra, J. Lin, J. Widjaja, C. Harpur et al., Polymorphism in human cytomegalovirus UL40 impacts on recognition of human leukocyte antigen-E (HLA-E) by natural killer cells. The Journal of biological chemistry, pp.8679-90, 2013.
DOI : 10.1074/jbc.m112.409672

URL : http://www.jbc.org/content/288/12/8679.full.pdf

P. Ljungman, M. Boeckh, H. Hirsch, F. Josephson, J. Lundgren et al., Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials Clinical infectious diseases: an official publication of the Infectious Diseases Society of America, pp.87-91, 2017.

E. Petrie, C. Clements, J. Lin, L. Sullivan, D. Johnson et al., CD94-NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequence. The Journal of experimental medicine, pp.725-760, 2008.
DOI : 10.1084/jem.20072525

URL : http://jem.rupress.org/content/jem/205/3/725.full.pdf

V. Braud, E. Jones, and A. Mcmichael, The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9, European Journal of Immunology, vol.4, issue.5, pp.1164-1173, 1997.
DOI : 10.1002/eji.1830270517

P. Mazzarino, G. Pietra, P. Vacca, M. Falco, D. Colau et al., Identification of effector-memory CMV-specific T???lymphocytes that kill CMV-infected target cells in an HLA-E-restricted fashion, European Journal of Immunology, vol.158, issue.11, pp.3240-3247, 2005.
DOI : 10.4049/jimmunol.169.10.5838

URL : http://onlinelibrary.wiley.com/doi/10.1002/eji.200535343/pdf

C. Deciphering-anti-hcmv-hla-e-restricted,

P. Klenerman and A. Oxenius, T cell responses to cytomegalovirus, Nature Reviews Immunology, vol.325, issue.6, pp.367-77, 2016.
DOI : 10.4049/jimmunol.1202665

L. Sullivan, C. Clements, J. Rossjohn, and A. Brooks, The major histocompatibility complex class Ib molecule HLA-E at the interface between innate and adaptive immunity, Tissue Antigens, vol.99, issue.5, pp.415-439, 2008.
DOI : 10.4049/jimmunol.173.9.5852

T. Van-hall, C. Oliveira, S. Joosten, and T. Ottenhoff, The other Janus face of Qa-1 and HLA-E: diverse peptide repertoires in times of stress. Microbes and infection, pp.12-13910, 2010.

T. Kraemer, A. Celik, T. Huyton, H. Kunze-schumacher, R. Blasczyk et al., HLA-E: Presentation of a Broader Peptide Repertoire Impacts the Cellular Immune Response???Implications on HSCT Outcome, Stem Cells International, vol.85, issue.5, pp.346714-26366178, 2015.
DOI : 10.1074/jbc.m503060200

S. Hansen, H. Wu, B. Burwitz, C. Hughes, K. Hammond et al., Broadly targeted CD8+ T cell responses restricted by major histocompatibility complex E, Science, vol.171, issue.3, pp.714-734, 2016.
DOI : 10.4049/jimmunol.171.3.1369

URL : http://science.sciencemag.org/content/351/6274/714.full.pdf

J. Michaelsson, T. De-matos, C. Achour, A. Lanier, L. Karre et al., A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NKG2A recognition. The Journal of experimental medicine, pp.1403-1417, 2002.

A. Celik, T. Kraemer, T. Huyton, R. Blasczyk, and C. Bade-doding, The diversity of the HLA-E-restricted peptide repertoire explains the immunological impact of the Arg107Gly mismatch, Immunogenetics, vol.175, issue.1, pp.29-41, 2016.
DOI : 10.4049/jimmunol.175.3.1383

G. Wang, P. Dash, J. Mccullers, P. Doherty, and P. Thomas, T cell receptor alphabeta diversity inversely correlates with pathogen-specific antibody levels in human cytomegalovirus infection):128ra42. https, Science translational medicine, vol.4, issue.128, p.3593633, 2012.
DOI : 10.1126/scitranslmed.3003647

URL : http://europepmc.org/articles/pmc3593633?pdf=render

V. Velu, R. Shetty, M. Larsson, and E. Shankar, Role of PD-1 co-inhibitory pathway in HIV infection and potential therapeutic options, Retrovirology, vol.175, issue.10, pp.14-4340294, 2015.
DOI : 10.4049/jimmunol.175.10.6368

URL : https://retrovirology.biomedcentral.com/track/pdf/10.1186/s12977-015-0144-x?site=retrovirology.biomedcentral.com

D. Barber, E. Wherry, D. Masopust, B. Zhu, J. Allison et al., Restoring function in exhausted CD8 T cells during chronic viral infection, Nature, vol.111, issue.7077, pp.682-689, 2006.
DOI : 10.1016/S0092-8674(02)01139-X

S. Simon, V. Vignard, L. Florenceau, B. Dreno, A. Khammari et al., PD-1 expression conditions T cell avidity within an antigen-specific repertoire):e1104448. https, Oncoimmunology, vol.5, issue.1, p.4760290, 2016.
DOI : 10.1080/2162402x.2015.1104448

URL : http://www.tandfonline.com/doi/pdf/10.1080/2162402X.2015.1104448?needAccess=true

R. Martinez and B. Evavold, Lower Affinity T Cells are Critical Components and Active Participants of the Immune Response. Frontiers in immunology, pp.468-4564719, 2015.
DOI : 10.3389/fimmu.2015.00468

URL : https://www.frontiersin.org/articles/10.3389/fimmu.2015.00468/pdf

S. Coupel, A. Moreau, M. Hamidou, V. Horejsi, J. Soulillou et al., Expression and release of soluble HLA-E is an immunoregulatory feature of endothelial cell activation, Blood, vol.109, issue.7, pp.2806-2820, 2007.
DOI : 10.1182/blood-2006-06-030213

URL : http://www.bloodjournal.org/content/bloodjournal/109/7/2806.full.pdf

H. Kim and H. Cantor, Regulation of self-tolerance by Qa-1-restricted CD8(+) regulatory T cells. Seminars in immunology, pp.446-52, 2011.
DOI : 10.1016/j.smim.2011.06.001

URL : http://europepmc.org/articles/pmc4631408?pdf=render

K. Van-meijgaarden, M. Haks, N. Caccamo, F. Dieli, T. Ottenhoff et al., Human CD8+ T-cells Recognizing Peptides from Mycobacterium tuberculosis (Mtb) Presented by HLA-E Have an Unorthodox Th2-like, Multifunctional, Mtb Inhibitory Phenotype and Represent a Novel Human T-cell Subset, PLOS Pathogens, vol.200, issue.3, p.4372528, 2015.
DOI : 10.1371/journal.ppat.1004671.s003

S. Takao, T. Ishikawa, K. Yamashita, and T. Uchiyama, The Rapid Induction of HLA-E Is Essential for the Survival of Antigen-Activated Naive CD4 T Cells from Attack by NK Cells, The Journal of Immunology, vol.185, issue.10, pp.6031-6071, 2010.
DOI : 10.4049/jimmunol.1000176

C. Bressollette-bodin, M. Coste-burel, B. Besse, E. Andre-garnier, V. Ferre et al., Cellular normalization of viral DNA loads on whole blood improves the clinical management of cytomegalovirus or Epstein Barr virus infections in the setting of pre-emptive therapy, Journal of Medical Virology, vol.37, issue.1, pp.90-98, 2009.
DOI : 10.1038/sj.bmt.1705289

I. Garrigue, M. Corte, N. Magnin, L. Couzi, S. Capdepont et al., Variability of UL18, UL40, UL111a and US3 immunomodulatory genes among human cytomegalovirus clinical isolates from renal Deciphering anti-HCMV HLA-E-restricted CD8 T-cell responses
DOI : 10.1016/j.jcv.2007.06.015